Catholic Medical Association Applauds HHS’s First Step Cancelling Contract for Medical Research Using Aborted Babies, However, Nearly $100 Million For Similar Experiments Remain

PHILADELPHIA, PA  – The Catholic Medical Association (CMA) along with the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), applauds the U.S. Department of Health and Human Services (HHS) first step in cancelling a contract for medical research using aborted babies, however nearly $100 million for similar experiments remain.

The CMA joined AAPLOG and dozens of other medical professional organizations (including the Christian Medical and Dental Association and American College of Pediatricians) in recently signing a letter denouncing the illegal trafficking of babies’ body parts and bringing this matter to the attention of the Trump administration.

HHS recently released a statement on the termination of the contract with Advanced Bioscience Resources Inc., (ABR) until ABR’s aborted fetal tissue procurement practices could be investigated further. The statement also announced an “audit of all acquisitions involving human fetal tissue to ensure conformity with the procurement and human fetal tissue research laws and regulations.” 

“While we are encouraged with the Trump Administration’s Department of HHS taking this first critical step to stop the epidemic of trafficking aborted baby parts, there needs to be more scrutiny of human fetal tissue acquisitions,” said Peter T. Morrow, M.D., President of the CMA.

“We applaud HHS for starting a long overdue review of all human fetal tissue acquisitions and contracts to ensure compliance with the law. HHS’s action is critically important to ensure that American’s tax dollars are used for research which does not violate the serious regulatory, moral and ethical considerations that the federal government is responsible to uphold,” said AAPLOG Executive Director Donna Harrison, M.D. 

HHS also promised a comprehensive review of all research involving fetal tissue to ensure consistency with statutes and regulations and will continue researching ethical alternatives to using fetal tissue.

Leave a Reply